Cedars Sinai 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2025
$ 27.00
Description Include: 1 video 11 pdf, size: 3.32 GB Target Audience: gastroenterologists, oncologists Sample video: contact me for sample video Information: Date & Location: Saturday, April 5, 2025, 7:30 AM – 1:00 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA Target Audience Specialties – Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology & Laboratory Medicine, Radiation Oncology, Radiology Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Occupational Therapist, Other (non-physician), Pharmacist, Physician, Researcher (non-physician) Overview The 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastricesophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients. Objectives Analyze advances in biomarkers and therapies to evaluate and synthesize treatment options for patients with gastroesophageal cancers. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence based national guidelines for treatment planning Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies Identify and implement optimal strategies for managing therapy related side effects and toxicities in patients treated with therapeutic agents Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team The 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2025 is tailored for a multidisciplinary group of healthcare professionals, with a strong focus on physicians involved in gastrointestinal cancer care. The target physician specialties include: Gastroenterology Oncology (especially GI oncology) Radiation oncology Pathology and laboratory medicine Endocrinology & metabolism Family and general medicine Medical genetics Nuclear medicine Pain management and palliative care Radiology The conference emphasizes precision medicine, immunotherapy, and biomarker strategies for cancers of the pancreas, liver, and gastroesophagus. It’s a valuable opportunity for physicians to gain cutting-edge insights and apply them directly to clinical decision-making Topics: *Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below April 5 Full Live.mp4 Agenda.pdf Cedars Sinai Health System.pdf How I treat liver metastases (surgical).pdf Molecular Landscape in CRC- Shaping the Future.pdf Overcoming obstacles to optimize care in Neuroendocrine tumors.pdf Social Media in Oncology.pdf Targeting KRAS in GI malignancies.pdf The Challenges of Treating Pancreatic Cancer.pdf Update in Surgical Management of Pancreatic Cancer.pdf Updates on the Management of Gastric Cancer.pdf Welcome and Introduction.pdf * Detail: Saturday, April 5, 2025 Disclosure and Accredidation Information 7:30AM – 7:40AM Registration Check In and Exhibits 7:30AM – 8:00AM Recording 8:00AM – 8:10AM Welcome and Introduction 8:00AM – 8:05AM Cedars Sinai Health System 8:05AM – 8:25AM David Hoffman, MD Targeting KRAS in GI malignancies 8:25AM – 8:45AM Ignacio Garrido-Laguna, MD, PhD, MBA Molecular Landscape in CRC: Shaping the Future 8:45AM – 9:05AM Jason A. Zell, DO, MPH Updates on the Management of Gastric Cancer 9:05AM – 9:25AM Dani Castillo, MD The Challenges of Treating Pancreatic Cancer 9:25AM – 9:45AM Vincent J. Picozzi, MD Update in Surgical Management of Pancreatic Cancer 9:45AM – 10:05AM Nicholas Nissen, MD Break and Exhibits 10:05AM – 10:25AM Panel Discussion: GI Cancer Cases 10:25AM – 10:45AM Kambiz Kosari, MD Katelyn Atkins, MD, PhD Jeremy Lorber, MD How I treat liver metastases (surgical) 10:45AM – 11:05AM Alexandra Gangi, MD Overcoming obstacles to optimize care in Neuroendocrine tumors 11:05AM – 11:25AM Emily Bergsland, MD Pick Up Lunch and Exhibits 11:25AM – 11:45AM Social Media in Oncology 11:45AM – 12:05PM Sumanta Pal, MD, FASCO Closing Remarks 12:05PM – 12:15PM
Call to order! 641-664-3990.


MENA Conference University of Chicago Blood Cancer and Gene Therapy Conference 2024
RNA Therapeutics Institute RNA Therapeutics From Concept to Clinic 2025
Memorial Sloan Kettering Cancer Center MSK Department of Pathology and Laboratory Medicine Alumni Meeting 2025